Results 71 to 80 of about 57,449 (202)

Buprenorphine – an attractive opioid with underutilized potential in treatment of chronic pain

Journal of Pain Research, 2015
Ish K Khanna, Sivaram PillarisettiNeuroPn Therapeutics, Alpharetta, GA, USAAbstract: Despite proven clinical utility, buprenorphine has not been used widely for the treatment of chronic pain.
Khanna IK, Pillarisetti S
doaj  

Ketamine-assisted buprenorphine initiation: a pilot case series

Addiction Science & Clinical Practice
Background Many people with opioid use disorder who stand to benefit from buprenorphine treatment are unwilling to initiate it due to experience with or fear of both spontaneous and buprenorphine-precipitated opioid withdrawal (BPOW).
Lucinda A. Grande, Tom Hutch, Keira Jack, Wendy Mironov, Jessica Iwuoha, Martin Muy-Rivera, Jacob Grillo, Stephen A. Martin, Andrew Herring   +8 more
doaj   +1 more source

Suboxone® (Buprenorphine/Naloxone) as an Agonist Opioid Treatment in Spain: A Budgetary Impact Analysis [PDF]

, 2009
José Martı́nez-Raga, Francisco González Saiz, César Pascual, Miguel Á. Casado, Francisco J. Sabater Torres   +4 more
openalex   +1 more source

‘Red Flags’ and ‘Red Tape’: Telehealth and pharmacy-level barriers to buprenorphine in the United States [PDF]

, 2022
Lauren Textor, Daniel J. Ventricelli, Shoshana V. Aronowitz   +2 more
openalex   +1 more source

Qualitative study of patients’ decisions to initiate injectable depot buprenorphine for opioid use disorder: the role of information and other factors [PDF]

, 2023
Joanne Neale, Stephen Parkin, John Strang   +2 more
openalex   +1 more source

Use of Smoking Cessation Methods Among Patients Receiving Office-based Buprenorphine Maintenance Treatment

, 2017
Pooja Shah, Chinazo O. Cunningham, Mia Brisbane, Joseph P. DeLuca, Shadi Nahvi   +4 more
openalex   +2 more sources

Serum Concentrations of a Long-acting Cat Formulation of Transdermal Buprenorphine in C57BL/6 Mice [PDF]

, 2023
Kathryn M Emmer, Kaci N Chlada, Valerie Bergdall   +2 more
openalex   +1 more source

Cross-sectional examination of characteristics of higher-dose buprenorphine prescriptions during the era of illicit fentanyl

Addiction Science & Clinical Practice
Background In response to greater illicit fentanyl use, buprenorphine daily doses exceeding the FDA’s recommended target daily dose (16 mg) and maximum suggested daily dose (24 mg) may provide better outcomes, but little is known about higher dosage ...
Bradley D. Stein, Flora Sheng, Brendan K. Saloner, Adam J. Gordon, Jessica S. Merlin   +4 more
doaj   +1 more source

Quick Opium Detoxification With 100 mg of Buprenorphine [PDF]

, 2016
Jamshid Ahmadi, Bahare Oji
openalex   +1 more source

Enhancing Patient Choice: Using Self-administered Intranasal Naloxone for Novel Rapid Buprenorphine Initiation

, 2022
Adam Randall, Ilana Hull, Stephen A. Martin   +2 more
openalex   +1 more source